apoE (131-162)+(244+272), hEP

General Information


DRACP ID  DRACP04002

Peptide Name   apoE (131-162)+(244+272), hEP

Sequence  EELRVRLASHLRKLRKRLLRDADDLQKRLAVYEEQAQQIRLQAEAFQARLKSWFEPLVEDM

Sequence Length  61

UniProt ID  P02649 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C327H539N101O93S

Absent amino acids  CGNT

Common amino acids  L

Mass  847598

Pl  10.01

Basic residues  14

Acidic residues  11

Hydrophobic residues  25

Net charge  3

Boman Index  -18940

Hydrophobicity  -74.1

Aliphatic Index  102.46

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  6990

Absorbance 280nm  116.5

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22334503

Title  Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding

Doi Not available

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  15389

DRACP is developed by Dr.Zheng's team.